Cystic Fibrosis Therapeutics Market Report by Drug Class (Pancreatic Enzyme Supplements, Mucolytics, Bronchodilators, CFTR Modulators, Antibiotics, and Others), Drug Molecule Type (Small Molecule Drugs, Biologics), Route of Administration (Oral Drugs, Inhaled Drugs), End-User (Hospitals, Clinics, and Others), and Region 2025-2033

Cystic Fibrosis Therapeutics Market Report by Drug Class (Pancreatic Enzyme Supplements, Mucolytics, Bronchodilators, CFTR Modulators, Antibiotics, and Others), Drug Molecule Type (Small Molecule Drugs, Biologics), Route of Administration (Oral Drugs, Inhaled Drugs), End-User (Hospitals, Clinics, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A2117

1   Preface
2   Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Cystic Fibrosis Therapeutics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Drug Class
    6.1    Pancreatic Enzyme Supplements
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Mucolytics
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Bronchodilators
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    CFTR Modulators
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Antibiotics
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Others
        6.6.1 Market Trends
        6.6.2 Market Forecast
7   Market Breakup by Drug Molecule Type
    7.1    Small Molecule Drugs
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Biologics
        7.2.1 Market Trends
        7.2.2 Market Forecast
8   Market Breakup by Route of Administration
    8.1    Oral Drugs
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Inhaled Drugs
        8.2.1 Market Trends
        8.2.2 Market Forecast
9   Market Breakup by End-User
    9.1    Hospitals
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Clinics
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Abbvie Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio 
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Alaxia
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    Alcresta Therapeutics Inc.
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio 
        15.3.4    Allergan
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio 
           15.3.4.3 Financials 
           15.3.4.4 SWOT Analysis
        15.3.5    AstraZeneca
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio 
           15.3.5.3 Financials 
           15.3.5.4 SWOT Analysis
        15.3.6    F. Hoffmann-La Roche Ltd
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
        15.3.7    Gilead Sciences Inc.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio 
           15.3.7.3 Financials 
           15.3.7.4 SWOT Analysis
        15.3.8    Merck & Co., Inc.
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials 
           15.3.8.4 SWOT Analysis
        15.3.9    Novartis AG
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio 
           15.3.9.3 Financials 
           15.3.9.4 SWOT Analysis
        15.3.10    Teva Pharmaceutical Industries Ltd.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio 
           15.3.10.3 Financials 
           15.3.10.4 SWOT Analysis
        15.3.11    Vertex Pharmaceuticals Inc.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio 
           15.3.11.3 Financials 
           15.3.11.4 SWOT Analysis

List of Figures

​Figure 1: Global: Cystic Fibrosis Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Cystic Fibrosis Therapeutics Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Cystic Fibrosis Therapeutics Market: Breakup by Drug Class (in %), 2024
Figure 4: Global: Cystic Fibrosis Therapeutics Market: Breakup by Drug Molecule Type (in %), 2024
Figure 5: Global: Cystic Fibrosis Therapeutics Market: Breakup by Route of Administration (in %), 2024
Figure 6: Global: Cystic Fibrosis Therapeutics Market: Breakup by End-User (in %), 2024
Figure 7: Global: Cystic Fibrosis Therapeutics Market: Breakup by Region (in %), 2024
Figure 8: Global: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 9: Global: Cystic Fibrosis Therapeutics (Pancreatic Enzyme Supplements) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Cystic Fibrosis Therapeutics (Pancreatic Enzyme Supplements) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Cystic Fibrosis Therapeutics (Mucolytics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Cystic Fibrosis Therapeutics (Mucolytics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Cystic Fibrosis Therapeutics (Bronchodilators) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Cystic Fibrosis Therapeutics (Bronchodilators) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Cystic Fibrosis Therapeutics (CFTR Modulators) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Cystic Fibrosis Therapeutics (CFTR Modulators) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Cystic Fibrosis Therapeutics (Antibiotics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Cystic Fibrosis Therapeutics (Antibiotics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Cystic Fibrosis Therapeutics (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Cystic Fibrosis Therapeutics (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Cystic Fibrosis Therapeutics (Small Molecule Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Cystic Fibrosis Therapeutics (Small Molecule Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Cystic Fibrosis Therapeutics (Biologics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Cystic Fibrosis Therapeutics (Biologics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Cystic Fibrosis Therapeutics (Oral Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Cystic Fibrosis Therapeutics (Oral Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Cystic Fibrosis Therapeutics (Inhaled Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Cystic Fibrosis Therapeutics (Inhaled Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Cystic Fibrosis Therapeutics (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Cystic Fibrosis Therapeutics (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Cystic Fibrosis Therapeutics (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Cystic Fibrosis Therapeutics (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Cystic Fibrosis Therapeutics (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Cystic Fibrosis Therapeutics (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: North America: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: North America: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: United States: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: United States: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Canada: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Canada: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Asia Pacific: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Asia Pacific: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: China: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: China: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Japan: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Japan: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: India: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: India: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: South Korea: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: South Korea: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Australia: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Australia: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Indonesia: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Indonesia: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Others: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Others: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Europe: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Europe: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Germany: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Germany: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: France: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: France: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: United Kingdom: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: United Kingdom: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Italy: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Italy: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Spain: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Spain: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Russia: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Russia: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Others: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Others: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Latin America: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Latin America: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Brazil: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Brazil: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Mexico: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Mexico: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Others: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Others: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Middle East and Africa: Cystic Fibrosis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Middle East and Africa: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Global: Cystic Fibrosis Therapeutics Industry: SWOT Analysis
Figure 84: Global: Cystic Fibrosis Therapeutics Industry: Value Chain Analysis
Figure 85: Global: Cystic Fibrosis Therapeutics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Cystic Fibrosis Therapeutics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Cystic Fibrosis Therapeutics Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
Table 3: Global: Cystic Fibrosis Therapeutics Market Forecast: Breakup by Drug Molecule Type (in Million USD), 2025-2033
Table 4: Global: Cystic Fibrosis Therapeutics Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
Table 5: Global: Cystic Fibrosis Therapeutics Market Forecast: Breakup by End-User (in Million USD), 2025-2033
Table 6: Global: Cystic Fibrosis Therapeutics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Cystic Fibrosis Therapeutics Market Structure
Table 8: Global: Cystic Fibrosis Therapeutics Market: Key Players

Cystic Fibrosis Therapeutics Market Report by Drug Class (Pancreatic Enzyme Supplements, Mucolytics, Bronchodilators, CFTR Modulators, Antibiotics, and Others), Drug Molecule Type (Small Molecule Drugs, Biologics), Route of Administration (Oral Drugs, Inhaled Drugs), End-User (Hospitals, Clinics, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials